AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.070
+0.010 (0.94%)
Mar 9, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -0 | 42.01 | -384.63 | -52.56 | -55.64 | -32.91 | Upgrade
|
| Depreciation & Amortization | 0.08 | 0.1 | 0.1 | 0.07 | 0 | - | Upgrade
|
| Other Amortization | - | - | - | 0.33 | 1.98 | 0.83 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 348 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.35 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | - | 0.14 | Upgrade
|
| Stock-Based Compensation | 5.07 | 6.25 | 7 | 5.89 | 5.22 | 4.79 | Upgrade
|
| Other Operating Activities | -15.82 | -69.35 | -15.55 | 4.41 | 18.59 | 16.59 | Upgrade
|
| Change in Accounts Payable | -2.11 | 2.52 | -4.59 | 6.61 | -0.9 | 0.67 | Upgrade
|
| Change in Other Net Operating Assets | -0.44 | -1.82 | 1.85 | -0.35 | 2.31 | 0.79 | Upgrade
|
| Operating Cash Flow | -13.22 | -20.29 | -47.83 | -35.58 | -28.43 | -9.46 | Upgrade
|
| Capital Expenditures | -0 | - | - | -0.31 | -0.17 | - | Upgrade
|
| Divestitures | - | - | - | - | - | -1.27 | Upgrade
|
| Investing Cash Flow | -0 | - | - | -0.31 | -0.17 | -1.27 | Upgrade
|
| Long-Term Debt Issued | - | 15 | 14 | 44.5 | 15 | 25.41 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.3 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -3.99 | - | - | Upgrade
|
| Total Debt Repaid | - | - | - | -3.99 | - | -0.3 | Upgrade
|
| Net Debt Issued (Repaid) | - | 15 | 14 | 40.51 | 15 | 25.11 | Upgrade
|
| Issuance of Common Stock | 18.61 | 0.15 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -1.44 | -0.54 | Upgrade
|
| Financing Cash Flow | 18.61 | 15.15 | 14 | 40.51 | 13.56 | 24.57 | Upgrade
|
| Net Cash Flow | 5.39 | -5.15 | -33.83 | 4.62 | -15.04 | 13.84 | Upgrade
|
| Free Cash Flow | -13.22 | -20.29 | -47.83 | -35.89 | -28.6 | -9.46 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -375.74% | Upgrade
|
| Free Cash Flow Per Share | -1.93 | -35.23 | -0.62 | -18.61 | -16.31 | -103.26 | Upgrade
|
| Levered Free Cash Flow | -7.08 | -10.3 | -25.48 | -16.79 | -14.85 | -2.94 | Upgrade
|
| Unlevered Free Cash Flow | -7.08 | -10.3 | -25.48 | -16.79 | -14.85 | -2.93 | Upgrade
|
| Change in Working Capital | -2.55 | 0.71 | -2.74 | 6.27 | 1.42 | 1.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.